20 articles
New research reveals intelectin-2 protein strengthens gut mucus while directly neutralizing harmful bacteria, including antibiotic-resistant strains.
A newly discovered bacteriophage inside common gut bacteria appears strongly linked to colorectal cancer, potentially explaining a long-standing medical paradox.
New mouse research reveals how intestinal aging creates a feedback loop of inflammation, barrier breakdown, and microbiome decline.
A Phase 1b trial shows a daily probiotic capsule may restore immunotherapy response in advanced melanoma patients who had stopped responding.
Scientists discover harmful bacterial sugars in the gut trigger immune attacks that damage the brain in ALS and dementia patients.
A Lactobacillus strain found in centenarians reduced lung fibrosis scores by 30% and collagen by 40% in aging mice via the gut-lung axis.
A gut microbe converts a common pollutant into an inflammation trigger linked to depression, revealing a new molecular pathway.
Johns Hopkins study reveals how oral bacteria can travel to breast tissue, causing DNA damage and accelerating tumor growth.
Singapore scientists developed a fluorescent nanosensor that rapidly measures a key gut microbiome molecule linked to inflammation and metabolic health.
Common respiratory bacterium persists in retinas and brains, triggering inflammation and amyloid buildup linked to cognitive decline.
A Nature Medicine study reveals how microglial state shifts drive Alzheimer's, pointing to a promising oral drug now in Phase 1 trials.
New research explores whether transplanting gut bacteria from vegans can reduce TMAO, a compound linked to heart disease, cancer, and diabetes.
Mouse study reveals the FXR bile acid receptor links gut microbes to arterial plaque in sleep apnea, hinting at new preventive targets.
Scientists discover friendly gut bacteria use injection systems to send proteins into human cells, influencing immunity and inflammation.
New research reveals that close social contact, not just shared environment, actively transfers gut microbes between household members.
New research proposes the immune system actively controls gut microbiome diversity, and that aging-related immune decline drives dysbiosis.
Bacteriophages could offer a breakthrough solution to combat the growing crisis of antibiotic-resistant infections threatening global health.
OLX-07010, an oral drug targeting toxic tau proteins, advances toward Phase 1b Alzheimer's trials after securing $1.9M NIH safety grant.
A molecule called OLE restores microglia's protective function, reducing amyloid plaques and improving memory in animal models.
A 12-week clinical trial found older adults taking probiotics with antidepressants had greater reductions in depression and anxiety than placebo.
